Mexico Newborn Screening Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$18.8

Forecast, 2030 (US$M)

$28.7

CAGR, 2024 - 2030

6.2%

Report Coverage

Mexico

Mexico newborn screening market, 2018-2030 (US$M)

Related Markets

Global Newborn Screening Industry Outlook

North America Newborn Screening Market Outlook

U.S. Newborn Screening Market Outlook

Canada Newborn Screening Market Outlook

Europe Newborn Screening Market Outlook

Germany Newborn Screening Market Outlook

France Newborn Screening Market Outlook

Italy Newborn Screening Market Outlook

Spain Newborn Screening Market Outlook

Denmark Newborn Screening Market Outlook

Sweden Newborn Screening Market Outlook

Norway Newborn Screening Market Outlook

UK Newborn Screening Market Outlook

Asia Pacific Newborn Screening Market Outlook

Japan Newborn Screening Market Outlook

China Newborn Screening Market Outlook

India Newborn Screening Market Outlook

Australia Newborn Screening Market Outlook

South Korea Newborn Screening Market Outlook

Thailand Newborn Screening Market Outlook

Latin America Newborn Screening Market Outlook

Argentina Newborn Screening Market Outlook

Brazil Newborn Screening Market Outlook

MEA Newborn Screening Market Outlook

South Africa Newborn Screening Market Outlook

Saudi Arabia Newborn Screening Market Outlook

UAE Newborn Screening Market Outlook

Kuwait Newborn Screening Market Outlook

Mexico newborn screening market highlights

The Mexico newborn screening market generated a revenue of USD 18.8 million in 2023 and is expected to reach USD 28.7 million by 2030.
The Mexico market is expected to grow at a CAGR of 6.2% from 2024 to 2030.
In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2023.
Tandem Mass Spectrometry is the most lucrative technology segment registering the fastest growth during the forecast period.

Newborn screening market data book summary

Market revenue in 2023	USD 18.8 million
Market revenue in 2030	USD 28.7 million
Growth rate	6.2% (CAGR from 2023 to 2030)
Largest segment	Tandem mass spectrometry
Fastest growing segment	Tandem Mass Spectrometry
Historical data	2018 - 2022
Base year	2023
Forecast period	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis
Key market players worldwide	Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp

Other key industry trends

In terms of revenue, Mexico accounted for 2.4% of the global newborn screening market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Latin America, Mexico newborn screening market is projected to lead the regional market in terms of revenue in 2030.
Argentina is the fastest growing regional market in Latin America and is projected to reach USD 27.4 million by 2030.

Tandem mass spectrometry was the largest segment with a revenue share of 25% in 2023. Horizon Databook has segmented the Mexico newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.

According to the National Law passed in 2005, all of the neonates require screening for hearing impairments and other congenital anomalies. In 2008, PerkinElmer along with the Ministry of Health agreed to expand the NBS program three folds in order to increase the capacity.

PerkinElmer provided the laboratories with instruments, reagents, and other consumables needed along with training and consultations with experts. They particularly provided the DELFIA Neonatal TSH kit for detection of congenital hypothyroidism. In 2009, the Audiology Department of Ministry of Health lined up funds to allocate screening instrumentation in 300 institutions.

Key Regions: U.S. , UK , Japan , Brazil , UAE